Inventor
OLIVE DANIEL
FR28 patents
⚠️ This page may combine multiple inventors who share the name “OLIVE DANIEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
INST NAT SANTE RECH MED
9 patentsUS7723482B2May 25, 2010
Anti-CD28 antibody
INST NAT SANTE RECH MED52 citations94
US9975950B2May 22, 2018
Antibodies directed against ICOS and uses thereof
INST NAT SANTE RECH MED5 citations82
US11180556B2Nov 23, 2021
Antibodies directed against ICOS and uses thereof
INST NAT SANTE RECH MED2 citations71
US10675357B2Jun 9, 2020
Antibodies having specificity to nectin-4 and uses thereof
INST NAT SANTE RECH MED3 citations71
US10633446B2Apr 28, 2020
Antibodies directed against ICOS and uses thereof
INST NAT SANTE RECH MED1 citations71
US5762933AJun 9, 1998
Method for preventing and treating graft failure in a human patient using a monoclonal antibody specific for leucocyte functional antigen LFA-1
INST NAT SANTE RECH MED8 citations63
US10273306B2Apr 30, 2019
Antibodies directed against ICOS for treating graft-versus-host disease
INST NAT SANTE RECH MED0 citations48
US10005839B2Jun 26, 2018
Antagonist of the BTLA/HVEM interaction for use in therapy
INST NAT SANTE RECH MED0 citations45
US11904004B2Feb 20, 2024
Anti-CD277 antibodies
INST NAT SANTE RECH MED0 citations43
IMCHECK THERAPEUTICS SAS
5 patentsUS11572409B2Feb 7, 2023
Antibodies having specificity for BTN2 and uses thereof
IMCHECK THERAPEUTICS SAS0 citations58
US11987631B2May 21, 2024
Anti-BTN3A antibodies and their use in treating cancer or infectious disorders
IMCHECK THERAPEUTICS SAS0 citations55
US11945871B2Apr 2, 2024
Anti-BTN3A antibodies and their use in treating cancer or infectious disorders
IMCHECK THERAPEUTICS SAS0 citations55
US12247075B2Mar 11, 2025
BTN3A binding proteins and uses thereof
IMCHECK THERAPEUTICS SAS0 citations51
US12258400B2Mar 25, 2025
Antibodies having specificity for BTN2 and uses thereof
IMCHECK THERAPEUTICS SAS0 citations50
OLIVE DANIEL
4 patentsUS8741295B2Jun 3, 2014
PD-1 antibodies and PD-L1 antibodies and uses thereof
OLIVE DANIEL87 citations96
US9243052B2Jan 26, 2016
Method for treating and diagnosing hematologic malignancies
OLIVE DANIEL14 citations74
US10716838B2Jul 21, 2020
Anti-CD277 antibodies
OLIVE DANIEL3 citations64
US8318166B2Nov 27, 2012
Ligands of HVEM for treating hematologic malignancies
OLIVE DANIEL4 citations60
INSERM (INSTITUT NAT DE LA SANTE ET DE LA RECH MEDICALE)
2 patentsUS9676852B2Jun 13, 2017
Antibodies directed against ICOS and uses thereof
INSERM (INSTITUT NAT DE LA SANTE ET DE LA RECH MEDICALE)8 citations82
US9695247B2Jul 4, 2017
Antibodies directed against ICOS for treating graft-versus-host disease
INSERM (INSTITUT NAT DE LA SANTE ET DE LA RECH MEDICALE)5 citations69